Qube Research & Technologies (QRT)
AVEO

Qube Research & Technologies (QRT)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-385,956
Closed -$5.77M – 3206
2022
Q4 		$5.77M Buy
385,956
+356,347
+1,204% +$4.93M 0.03% 626
2022
Q3 		$244K Buy
29,609
+10,859
+58% +$83.4K ﹤0.01% 1704
2022
Q2 		$123K Buy
+18,750
New +$90.8K ﹤0.01% 1868
2021
Q3 		– Sell
-17,928
Closed -$118K – 3057
2021
Q2 		$118K Buy
+17,928
New +$124K ﹤0.01% 1919

Qube Research & Technologies (QRT)'s AVEO Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 385,956 shares — an estimated $5.77M sold.

Qube Research & Technologies (QRT) first reported a position in AVEO in Q2 2021 and held it in 4 quarters. The position peaked at $5.77M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Qube Research & Technologies (QRT) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 385,956 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $5.77M.
  • Qube Research & Technologies (QRT) first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s AVEO Pharmaceuticals, Inc. position peaked at $5.77M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.